Hematopoietic stem cell transplantation for severe autoimmune diseases: Progress and perspectives

Cellular Therapy and Transplantation

Volumn 2, Issue 6, 2011, Pages

  Marmont, Alberto M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmune diseases; Hematopoietic stem cell transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; RITUXIMAB;

ALLERGIC ENCEPHALOMYELITIS; ALLOTRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; RHEUMATOID ARTHRITIS; SAFETY; WHOLE BODY RADIATION;

EID: 84856929803     PISSN: 1867416X     EISSN: 18668836     Source Type: Journal    
DOI: 10.3205/ctt-2011-en-000063.01     Document Type: Article

References (63)

1. Abrahamsson S, Muraro PA. Immune re-education following autologous stem cell transplantation. Autoimmunity. 2008;41:577-584. doi: 10.1080/08916930802197081.
2. Alderuccio F, Chan J, Ban-Hock T. Tweaking the immune system: Gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatmemnt for autoimmune diseases. Autoimmunity. 2008;41:679-685. doi: 10.1080/08916930802197123.
3. Alexander T, Thiel A, Rosen O, et al. Depletion of autoreacti-ve immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood. 2008;113:214-223. doi: 10.1182/ blood-2008-07-168286.
4. Aschwanden M, Daikeler T, Jeager KA, et al. Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis. 2008;67:1057-1059.
5. Brodsky RA and Jones R. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: Advantages and disadvantages. Autoimmunity. 2008;41:596-600. doi: 10.1080/08916930802197206.
6. Burt RK, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for non-malignant diseases. JAMA. 2008;299:925-936.
7. Burt RK, Oyama Y, Verda L, et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chime-rism. Arthritis Rheum. 2004;50:2466-2470. doi: 10.1002/art.20451.
8. Burt RK, Traynor A, Statkute I, et al. Nonmyeloablative hemato-poietic stem cell transplantation for systemic lupus erythematosus. JAMA. 2006;295:527-535.
9. Carson KR, Evens AM, Richey EA, et al. Progressive multifo-cal leukoencephalopathy following rituximab therapy in HIV-nega-tive patients: a report of 57 cases from the Research on Adverse Drug Events (RADAR) project. Blood. 2009;113:4834-4840. doi: 10.1182/blood-2008-10-186999.
10. Daikeler T, Hugle T, Farge D, et al. Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant. 2009; Epub ahead of print. doi: 10.1038/bmt.2008.424.
11. Dubinsky AN, Burt RK, Martin R, Muraro PA. T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft. Bone Marrow Transplant. 2009;43:1-7. doi: 10.1038/bmt.2009.139.
12. Eggleton P, Haigh R and Winyard PG. Consequence of neo-anti-genicity of the "altered self". Rheumatology. 2008;47:367-371. doi: 10.1093/rheumatology/ken014.
13. Elhasid R, Rowe JM, Berkowitz D, et al. Disappearance of diffuse calcinosis following autologous stem cell transplantati on in a child with autoimmune disease. Bone Marrow Transplant. 2004;33:1257-9. doi: 10.1038/sj.bmt.1704514.
14. Farge D, Labopin M, Tyndall A, et al. Autologous hematopoietic stem cell transplantation [AHSCT] for autoimmune diseases: an ob servational study 12 years of experience from the European Group for Blood and Marrow Transplantation [EBMT] Working Party on Autoimmune Diseases. Haematologica. 2009. Epub ahead of print. doi: 10.3324/haematol.2009.013458.
15. Goodnough CC, Sprent J, Fazekas de Groth and Vinnesa CG. Cellular and genetic mechanisms of self tolerance and autoimmuni-ty. Nature. 2005;435:590-597. doi: 10.1038/nature03724.
16. Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous haematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 2005;15:869-879. doi: 10.1038/ sj.bmt.1704892.
17. Griffth LM, Pavletic SZ, Tyndall A, et al. Feasibility of allo-geneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Cancer Institute sponsored International Workshop. Biol Blood Marrow Transoplant. 2005;11:862-870. doi:10.1016/j.bbmt.2005.07.009.
18. Hertenstein B, Hambach L, Bacigalupo A, et al. Development of leukemia in donor cells after allogeneic stem cell transplantation - a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2005;90:969-975.
19. Hinterberger W, Hinterberger-Fischer M, Marmont AM. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favourably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant. 2002;30:753-759.
20. Hoyer BE, Manz RA, Radbruch A, Hiepe F. Long-lived plasma cells and their contribution to autoimmunity. Ann NY Acad Sci. 2005;1050:124-33. doi: 10.1196/annals.1313.014.
21. Ikehara S. A novel method of bone marrow transplantation [BMT] for intractable autoimmune diseases. J Autoimmunity. 2008;30:108-115.
22. Ikehara S. Treatment of autoimmune diseases by hematopoietic bone marrow transplantation. Exp Hematol. 2001;29:661-669.
23. Illei GG. Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty? Arthritis Rheum. 2006;54:3730-3734. doi: 10.1002/art.22257.
24. Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood. 2008;112:4371-4383. doi: 10.1182/ blood-2008-03-077974.
25. Le Blanc K, Frassoni F, Ball I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe acute graft-versus-host disease. A phase II study. Lancet. 2008;371:1579-1586. doi: 10.1016/S0140-6736(08)60690-X.
26. Lowenthal R, Francis H, Gill D. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant. J Rheumatol. 2006;33:812-813.
27. Mancardi GL, Saccardi R, Filippi M, et al. Autologous hemato-poietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology. 2001;57:62-68.
28. Marmont AM [Guest Editor]. Hematopoietic stem cell transplantation in autoimmune diseases. Autoimmunity. 2008;41:556-690.
29. Marmont AM and Burt RK. Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin disorders. Autoimmunity. 2008;41:639-647. doi: 10.1080/08916930802198345.
30. Marmont AM, Gratwohl A, Vischer T and Tyndall A. Haemo-poietic precursor cell transplants for autoimmune diseases. Lancet. 1995;345:978.
31. Marmont AM, Gualandi F, Occhini D, et al. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Auto-immunity. 2006;39:505-511. doi: 10.1080/08916930600847598.
32. Marmont AM, van Lint MT, Gualandi F and Bacigalupo A. Au- tologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus. 1997;6:545-548.
33. Marmont AM. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Practice Research Clin Haematol. 2004;17:223-232. doi: 10.1016/j.beha.2004.04.004.
34. Marmont AM. Historical perspective and rationale of HSCT for autoimmune diseases. In Burt RK, Marmont AM [eds]: Stem cell therapy for autoimmune diseases. Landes Bioscience, Georgetown, 2004.
35. Marmont AM. Is there any evidence of a graft-versus autoimmu-nity effect in allogeneic transplantation? Blood Marrow Transplant Rev. 2004;4:11.
36. Marmont AM. Perspective: immunoablation with stem cell rescue: a possible cure for systemic lupus erythematosus? Lupus. 1993;2:151-156.
37. McColl G, Koshaka H, Wicks I. High-dose chemotherapy and syngeneic hemopoietic stem cell transplantation for severe serone-gative rheumatoid arthritis. Ann Intern Med. 1999;131:550-3.
38. McKendry RJ, Huebsch L and Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation: a case report with a 13 year follow-up. Arthritis Rheum. 1996;39:1246-53.
39. Metz I, Lucchinetti C, Openshaw H, et al. Autologous hemato-poietic stem cell transplantation fails to stop demyelination and neu-rodegeneration in multiple scleroris. Brain. 2007;130:1254-1262. doi: 10.1093/brain/awl370.
40. Mondria T, Lamers CH, te Bockhorst PA, et al. Bone marrow transplantation fails to halt intrathecal lymphocyte actrivation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008;79:1013-1015. doi: 10.1136/jnnp.2007.133520.
41. Moore J, Ma D, Will R, et al. A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;34:241-247. doi: 10.1038/sj.bmt.1704570.
42. Muraro P, Douek DC. Renewing the T-cell repertoire to arrest autoimmune aggression. Trends Immunol. 2006;27:61-67. doi: 10.1016/j.it.2005.12.003.
43. Nash RA, MC Sweeney PA, Crofford LJ, et al. High-dose immu-nosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood. 2007;110:1388-1396. doi: 10.1182/ blood-2007-02-072389.
44. Nauta HJ and Fibbe WE. Immunomodulatory properties of mes-enchymal stromal cells. Blood. 2007;110:3499-3506. doi: 10.1182/ blood-2007-02-069716.
45. Ozyurek E, Cowan MJ, Koeper MA, et al. Increasing mixed chimerism and the risk of graft loss in children undergoing allo-geneic hematopoietic stem cell transplantation for non-malignant disorders. Bone Marrrow Transplant. 2008;42:83-91. doi: 10.1038/ bmt.2008.89.
46. Pavletic SZ. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for autoimmune diseases. Arthritis Rheum. 2004;50:2387-2390. doi: 10.1002/art.20452.
47. Saccardi R and Gualandi F. Hematopoietic stem cell transplantation procedures. Autoimmunity. 2008;41:570-576. doi: 10.1080/08916930802197776.
48. Saccardi R, Di Gioia M and Bosi A. Haematopoietic stem cell transplantation for autoimmune disorders. Current Opinion Hema-tol. 2008;594-600.
49. Shevchenko YL, Novik AA, Kuznetsov AN, et al. High dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Exp Hematol. 2008;36:922-928. doi: 10.1016/j.exphem.2008.03.001.
50. Smith-Berdan S, Gille D, Weissman I, Christensen JL. Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purifed allogeneic hematopoietic stem cells. Blood. 2007;110:1370-1378. doi: 10.1182/blood-2007-03-081497.
51. Storek J, Zhao Z, Liu Y, et al. Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and auto-logous CD34 cell transplantation. Biol Blood Marrow Transplant. 2008;14:1373-1379. doi: 10.1016/j.bbmt.2008.09.013.
52. Sun W, Popat V, Hutton G, et al. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from auto-logous haematopoietic stem-cell graft in multiple sclerosis. Brain. 2004;127:996-1008.
53. Sykes M and Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature. 2005;435:620-627. doi: 10.1038/nature03728.
54. Tamm M, Gratwohl A, Tichelli A, et al. Autologous haemopoi-etic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease. Ann Rheum Dis. 1996;55:779-780.
55. Tapprich C, Fenk K, Schneider P, et al. Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma. Bone Marrow Transplant. 2003;32:629-31. doi: 10.1038/sj.bmt.1704183.
56. Uccelli A, Mancardi GL and Chiesa S. Is there a role for mes-enchymal stem cells in autoimmune diseases? Autoimmunity. 2008;41:392-395. doi:10.1080/08916930802200166.
57. Urban C, Lackner H, Sovinz P, et al. Succesful unrelated cord blood transplantation in a 7- year old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation. Eur J Haematol. 2006;76:326-330. doi: 10.1111/ j.0902-4441.2006.t01-1-EJH2549.x.
58. van Bekkum DW. Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Practice & Research Clin Haematol. 2004;17:201-222. doi:10.1016/j.beha.2004.04.003.
59. van Oosterhout M, Verburg RJ, Levahrt EW, et al. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host antibodies and synovial abnormalities. Ann Rheum Dis. 2005;64:1783-5. doi: 10.1136/ard.2004.034793.
60. van Wijmeersch B, Spranger B, Rutgeers O, et al. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a Graft-versus-Autoimmu-nity effect. Biol Blood Marrow Transplant. 2007;13:627-637. doi: 10.1016/j.bbmt.2007.03.001.
61. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous non-myeloablative hematopoietic stem cell transplantation in newly diagnosed type I diabetes mellitus. JAMA. 2007;297:1568-1576. doi:10.1001/jama.297.14.1568.
62. Young N, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509-2518. 10.1182/blood-2006-03-010777.
63. Zhang L, Bertucci AM, Ramsey-Goldman R, Burt RK, et al. Regulatory T cell (treg) subset return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remisison of lupus. J Immunol. 2009;183:6346-6358. doi: 10.4049/jimmunol.0901773.